Precigen Inc (PGEN)
Healthcare
Biotechnology
6.50 $
-1.2%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures per share in USD.
| Tick rows to compare them in a chart (up to 4) | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.41 | 2.52 | 0.58 | 0.73 | 1.56 | 1.62 | 1.92 | 1.24 | 0.21 | 0.19 | 0.07 | 0.13 | 0.03 | 0.01 | 0.03 | |
| – | 11.57 | 1.18 | 0.19 | 0.58 | 0.52 | 0.52 | 0.49 | 0.03 | 0.27 | 0.27 | 0.03 | 0.03 | 0.02 | 0.02 | |
| 1.41 | -9.06 | -0.60 | 0.53 | 0.99 | 1.10 | 1.40 | 0.75 | 0.17 | -0.08 | -0.20 | 0.10 | 0.00 | 0.00 | 0.01 | |
| 12.40 | 11.60 | 1.18 | 0.59 | 1.33 | 0.95 | 1.19 | 3.12 | 0.26 | 0.24 | 0.24 | 0.24 | 0.20 | 0.20 | 0.13 | |
| – | 4.50 | 0.82 | 0.64 | 0.98 | 1.21 | 1.22 | 1.06 | 0.65 | 0.55 | 0.37 | 0.24 | 0.17 | 0.15 | 0.23 | |
| 15.97 | 16.10 | 2.00 | 1.24 | 2.31 | 2.16 | 2.41 | 4.19 | 0.73 | 0.44 | 0.27 | 0.48 | 0.41 | 0.50 | 0.36 | |
| -14.55 | -13.58 | -1.42 | -0.71 | -1.32 | -1.06 | -1.15 | -3.90 | -0.56 | -0.52 | -0.46 | -0.38 | -0.41 | -0.50 | -0.35 | |
| 0.03 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.07 | 0.12 | 0.11 | 0.09 | 0.03 | 0.00 | 0.00 | 0.01 | |
| -15.05 | -14.80 | -1.00 | -0.86 | -0.78 | -1.65 | -1.08 | -4.14 | -0.68 | -0.63 | -0.56 | -0.40 | -0.39 | -0.48 | -0.82 | |
| 0.03 | -0.06 | -0.24 | 0.00 | 0.01 | -0.03 | -0.02 | -0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | |
| -15.05 | -14.80 | -0.95 | -0.83 | -0.76 | -1.58 | -0.98 | -3.93 | -1.11 | -1.02 | -0.47 | 0.14 | -0.39 | -0.47 | -0.82 | |
| -14.26 | -13.34 | -0.82 | -0.75 | -0.61 | -1.43 | -0.82 | -2.69 | -0.45 | -0.41 | -0.39 | -0.31 | -0.36 | -0.46 | -0.80 |
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.